AzTrials
AzTrials

Coronary Stent RestenosisNCT00226525

Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation

A study testing skin sensitivity test in people with Coronary Stent Restenosis, run by Hadassah Medical Organization at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This trial is intended to find wether there is a connection between allergy to metals and reooclusion of stents in the coronary arteries Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Stent Restenosis
What is being tested?
skin sensitivity test
Type of treatment
Surgery or procedure
How many people
150 participants
Where
1 siteIsrael
Study dates
Feb 2005to Aug 2006
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with 2 cardiac catheterization in one years time and in the first one stent implantation

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Hadassah Medical Center

    Jerusalem

Other trials in Israel

About this study

Official title: Rate of Metal Skin Allergy in Cohorts of Patients With and Without Coronary Stent Restenosis

This trial is intended to find wether there is a connection between allergy to metals and reooclusion of stents in the coronary arteries

Being tested
skin sensitivity test
Keywords
Restenosis, skin metal allergy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • skin sensitivity testProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The rate of skin delayed type hypersensitivity to metals among patients with restenosis and without restenosis

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2005 (estimated)
  2. Study startFeb 2005
  3. Study completionAug 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
150 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00226525
Sponsor's protocol ID
20-03.09.04-HMO-CTIL
Status last verified
Sep 2006
First submitted
10 Jul 2005
Last updated
7 Nov 2006
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing skin sensitivity test in people with Coronary Stent Restenosis, run by Hadassah Medical Organization at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Nov 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The rate of skin delayed type hypersensitivity to metals among patients with restenosis and without restenosis. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2006.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in